Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Eaton Vance Total Return Bond ETF
EVTR
$5.7B
| $1.45B | 0.09% |
28,229,610
+5,473,066
| +24% | +$283M |
|
202
O'Reilly Automotive
ORLY
$76.3B
| $1.45B | 0.09% |
15,899,133
-726,975
| -4% | -$71M |
|
203
Duke Energy
DUK
$97.3B
| $1.45B | 0.09% |
12,340,630
-111,204
| -0.9% | -$13.6M |
|
204
US Bancorp
USB
$99.6B
| $1.45B | 0.09% |
27,087,096
-350,110
| -1% | -$17.2M |
|
205
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
| $1.43B | 0.09% |
15,236,841
+465,870
| +3% | +$43.9M |
|
206
Strategy Inc
MSTR
$38.4B
| $1.43B | 0.09% |
9,380,398
+963,416
| +11% | +$222M |
|
207
SLB Ltd
SLB
$75B
| $1.42B | 0.09% |
37,095,243
+482,533
| +1% | +$17.5M |
|
208
Energy Transfer Partners
ET
$69.3B
| $1.42B | 0.09% |
86,310,272
+25,366,594
| +42% | +$422M |
|
209
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.5B
| $1.42B | 0.09% |
2,961,548
-1,251,185
| -30% | -$592M |
|
210
MSCI
MSCI
$40.9B
| $1.42B | 0.08% |
2,467,556
+52,242
| +2% | +$29.3M |
|
211
Vertex Pharmaceuticals
VRTX
$126B
| $1.41B | 0.08% |
3,120,310
+11,905
| +0.4% | +$5.13M |
|
212
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $1.4B | 0.08% |
11,491,683
+882,718
| +8% | +$101M |
|
213
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
| $1.4B | 0.08% |
20,152,942
+940,590
| +5% | +$63.9M |
|
214
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $1.4B | 0.08% |
23,769,661
+1,685,710
| +8% | +$99.1M |
|
215
Coupang
CPNG
$29.2B
| $1.39B | 0.08% |
58,860,223
-9,230,846
| -14% | -$263M |
|
216
Vanguard FTSE Europe ETF
VGK
$31.4B
| $1.36B | 0.08% |
16,250,731
-2,943,014
| -15% | -$239M |
|
217
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
| $1.35B | 0.08% |
22,609,003
+2,778,949
| +14% | +$167M |
|
218
iShares Core Dividend Growth ETF
DGRO
$43.5B
| $1.34B | 0.08% |
19,366,070
+331,748
| +2% | +$22.8M |
|
219
Corning
GLW
$143B
| $1.33B | 0.08% |
15,206,561
-192,294
| -1% | -$16.6M |
|
220
EQT Corp
EQT
$32.3B
| $1.33B | 0.08% |
24,744,626
+765,300
| +3% | +$43M |
|
221
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
| $1.32B | 0.08% |
11,948,409
+1,816,021
| +18% | +$202M |
|
222
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
| $1.32B | 0.08% |
29,438,378
-1,166,912
| -4% | -$52M |
|
223
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$40.9B
| $1.31B | 0.08% |
22,507,866
+1,408,923
| +7% | +$81.9M |
|
224
3M
MMM
$94.3B
| $1.3B | 0.08% |
8,132,442
+2,301
| +0% | +$376K |
|
|
BNY
225
Bank of New York Mellon
BNY
$107B
| $1.3B | 0.08% |
11,195,018
-3,440,848
| -24% | -$381M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.